STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,663,336 | -62.9% | 3,721,659 | 0.0% | 1.03% | -68.7% |
| Q2 2023 | $39,561,235 | +44.8% | 3,721,659 | +13.5% | 3.28% | +2.2% |
| Q1 2023 | $27,315,252 | +295.6% | 3,279,142 | +338.3% | 3.21% | +344.3% |
| Q4 2022 | $6,904,750 | -30.1% | 748,077 | -2.7% | 0.72% | -23.6% |
| Q3 2022 | $9,876,000 | -50.5% | 769,169 | -49.0% | 0.94% | -50.9% |
| Q2 2022 | $19,942,000 | -33.3% | 1,509,620 | +6.3% | 1.93% | -33.1% |
| Q1 2022 | $29,902,000 | +337.5% | 1,420,530 | +380.8% | 2.88% | +364.2% |
| Q4 2021 | $6,835,000 | +648.6% | 295,425 | +722.9% | 0.62% | +1341.9% |
| Q3 2021 | $913,000 | – | 35,899 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |